Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presents Q2 2022 financial results and provides a strategy update with 2027 long-term financial targets. The presentation discusses generic and specialty pharmaceutical business performance, including branded products such as AUSTEDO, AJOVY, and COPAXONE, alongside updates on opioid litigation matters.
earnings
37 Pages
earnings
16 Pages
Nestlé Malaysia Berhad
Discover Financial Services 3Q16 Earnings Results
earningsearnings
12 Pages
Discover Financial Services
Vertex Pharmaceuticals Q1 2022 Financial Results
earningsearnings
18 Pages
Vertex Pharmaceuticals